CYTOSORBENTS CORPORATION (CTSO) Operating cash flow 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.4MFY2025 · since FY2016: -$6.7M → -$12.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.4M | +14.2% |
| FY2024 | -$14.4M | +33.4% |
| FY2023 | -$21.7M | +23.3% |
| FY2022 | -$28.2M | -101.6% |
| FY2021 | -$14.0M | -149.5% |
| FY2020 | -$5.6M | +66.5% |
| FY2019 | -$16.8M | -54.6% |
| FY2018 | -$10.8M | -67.8% |
| FY2017 | -$6.5M | +4.0% |
| FY2016 | -$6.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice